Page last updated: 2024-09-03

iodoazomycin arabinoside and Carcinoma, Hepatocellular

iodoazomycin arabinoside has been researched along with Carcinoma, Hepatocellular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kumar, P; Narain, R; Quan, S; Wang, Y; Zhou, A	1

Other Studies

1 other study(ies) available for iodoazomycin arabinoside and Carcinoma, Hepatocellular

Article	Year
Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma. Biomacromolecules, 2015, Jul-13, Volume: 16, Issue:7 Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Galactose; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanogels; Nitroimidazoles; Polyethylene Glycols; Polyethyleneimine; Radiation-Sensitizing Agents; Temperature; Theranostic Nanomedicine	2015

Article

Year

Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.

Biomacromolecules, 2015, Jul-13, Volume: 16, Issue:7

Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Galactose; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanogels; Nitroimidazoles; Polyethylene Glycols; Polyethyleneimine; Radiation-Sensitizing Agents; Temperature; Theranostic Nanomedicine

2015